Skip to main content

Human Enhancement Drugs and Novel Approaches to Harm Reduction

Edited by:

Timothy Piatkowski, PhD, Griffith University, Australia
Professor James McVeigh, PhD, Manchester Metropolitan university, United Kingdom

Submission Status: Open   |   Submission Deadline: (Day Month Year) 
 

Harm Reduction Journal is calling for submissions to our Collection on Human Enhancement Drugs and Novel Approaches to Harm Reduction.


Image credit: © XXXXX

New Content ItemThis Collection supports and amplifies research related to SDG [add SDG number]: [add SDG name and hyperlink to SN SDG site for the specific SDG].

About the Collection

Collection description

There are currently no articles in this collection.

Submission Guidelines

Back to top

This Collection welcomes submission of [types of articles]. Should you wish to submit a different article type, please read our submission guidelines [hyperlink to journal's submission guidelines] to confirm that type is accepted by the journal. 

USE IF SNAPP JOURNAL - Articles for this Collection should be submitted via our submission system, Snapp [hyperlink to journal's Snapp submission URL]. Please, select the appropriate Collection title “xxxxx" under the “Details” tab during the submission stage.

USE IF EDITORIAL MANAGER JOURNAL - Articles for this Collection should be submitted via our submission system, Editorial Manager [hyperlink to Journal’s EM submission link]. Please select the appropriate Collection title “xxxxx" from the dropdown menu.

Articles will undergo the journal’s standard peer-review process [hyperlink to journal's About page] and are subject to all the journal’s standard policies. Articles will be added to the Collection as they are published.

The Editors have no competing interests with the submissions which they handle through the peer-review process. The peer-review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.